Conavi Medical Statistics
Total Valuation
Conavi Medical has a market cap or net worth of 25.51 million. The enterprise value is 31.82 million.
| Market Cap | 25.51M |
| Enterprise Value | 31.82M |
Important Dates
The last earnings date was Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 76.75M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +545.55% |
| Shares Change (QoQ) | +54.88% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 42.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.77 |
| PB Ratio | -2.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.46 |
| EV / Sales | 4.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.75 |
Financial Position
The company has a current ratio of 2.14
| Current Ratio | 2.14 |
| Quick Ratio | 1.88 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.81 |
| Interest Coverage | -1.17 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -70.95% |
| Return on Invested Capital (ROIC) | -240.62% |
| Return on Capital Employed (ROCE) | -140.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +719.38% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +719.38% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.39 |
| Relative Strength Index (RSI) | 50.25 |
| Average Volume (20 Days) | 7,171 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Conavi Medical had revenue of 6.77 million and -21.86 million in losses. Loss per share was -0.55.
| Revenue | 6.77M |
| Gross Profit | 5.37M |
| Operating Income | -11.72M |
| Pretax Income | -21.86M |
| Net Income | -21.86M |
| EBITDA | -11.40M |
| EBIT | -11.72M |
| Loss Per Share | -0.55 |
Balance Sheet
The company has 8.27 million in cash and 14.67 million in debt, giving a net cash position of -6.40 million.
| Cash & Cash Equivalents | 8.27M |
| Total Debt | 14.67M |
| Net Cash | -6.40M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -8.64M |
| Book Value Per Share | -0.11 |
| Working Capital | 5.24M |
Cash Flow
In the last 12 months, operating cash flow was -18.03 million and capital expenditures -162,040, giving a free cash flow of -18.19 million.
| Operating Cash Flow | -18.03M |
| Capital Expenditures | -162,040 |
| Free Cash Flow | -18.19M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 79.35% |
| Operating Margin | -173.12% |
| Pretax Margin | -322.74% |
| Profit Margin | n/a |
| EBITDA Margin | -168.28% |
| EBIT Margin | -173.12% |
| FCF Margin | n/a |
Dividends & Yields
Conavi Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -545.55% |
| Shareholder Yield | n/a |
| Earnings Yield | -85.68% |
| FCF Yield | -71.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Conavi Medical has an Altman Z-Score of -13.99 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.99 |
| Piotroski F-Score | 4 |